Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01849978 · ClinicalTrials.gov registry record · NA

Enhancing Exercise in Breast Cancer Survivors

A NA study of Breast Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
81
Enrollment target
1
Study location

NCT01849978 is a NA study of Breast Cancer that has completed, run by Duke University. The registered enrollment target is 81 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01849978, a NA study of Breast Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
81 participants
Enrollment target
1
Study location

Study Summary

This study will examine whether or not providing early stage breast cancer survivors with tips on making exercise more enjoyable promotes greater levels of moderate to strenuous exercise.

Conditions Studied

Interventions

  • BEHAVIORAL Newsletter about physical activity and breast cancer survivors
  • BEHAVIORAL Changing your habits brochure
  • BEHAVIORAL Tips for making exercise enjoyable and personally-valued
  • BEHAVIORAL Testimonials from breast cancer survivors

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2014-05
Est. Completion 2015-04
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01849978

The ClinicalTrials.gov registry entry for NCT01849978 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Newsletter about physical activity and breast cancer survivors is the first listed.

NCT01849978 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01849978 about?

NCT01849978 is a clinical study titled "Enhancing Exercise in Breast Cancer Survivors". This study will examine whether or not providing early stage breast cancer survivors with tips on making exercise more enjoyable promotes greater levels of moderate to strenuous exercise.

What is the current status of trial NCT01849978?

This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2014-05. Estimated completion is 2015-04.

What conditions does trial NCT01849978 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01849978?

The interventions under investigation include: Newsletter about physical activity and breast cancer survivors (BEHAVIORAL), Changing your habits brochure (BEHAVIORAL), Tips for making exercise enjoyable and personally-valued (BEHAVIORAL), Testimonials from breast cancer survivors (BEHAVIORAL).

Who is sponsoring clinical trial NCT01849978?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01849978 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.